NCT06719115View on ClinicalTrials.gov

A Clinical Trial to Investigate the Safety and Efficacy of D-Mannose on Symptoms of Urinary Tract Infection in Women

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 3, 2023

Primary Completion Date

June 20, 2024

Study Completion Date

June 20, 2024

Conditions
Urinary Tract Infection(UTI)
Interventions
DIETARY_SUPPLEMENT

UClear

Take one dose twice a day for three days with or without food, starting on Day 1 (baseline visit).

OTHER

Placebo

Take one dose twice a day for three days with or without food, starting on Day 1 (baseline visit).

Trial Locations (1)

N6B3L1

KGK Science Inc., London

Sponsors

Collaborators (1)

KGK Science Inc.
All Listed Sponsors
collaborator

KGK Science Inc.

INDUSTRY

lead

KEB Nutraceuticals USA, Inc.

INDUSTRY

NCT06719115 - A Clinical Trial to Investigate the Safety and Efficacy of D-Mannose on Symptoms of Urinary Tract Infection in Women | Biotech Hunter | Biotech Hunter